Summit Financial’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Buy
15,063
+1,229
+9% +$110K 0.02% 695
2025
Q4
$1.09M Sell
13,834
-1,367
-9% -$107K 0.02% 636
2025
Q3
$1.22M Sell
15,201
-140
-0.9% -$11.9K 0.02% 589
2025
Q2
$1.39M Buy
15,341
+942
+7% +$86K 0.03% 354
2025
Q1
$1.35M Buy
14,399
+265
+2% +$23.7K 0.04% 319
2024
Q4
$1.28M Buy
14,134
+807
+6% +$77K 0.05% 272
2024
Q3
$1.38M Buy
13,327
+3,302
+33% +$337K 0.05% 215
2024
Q2
$973K Buy
10,025
+3,000
+43% +$277K 0.04% 230
2024
Q1
$633K Sell
7,025
-276
-4% -$23.4K 0.04% 227
2023
Q4
$582K Buy
7,301
+78
+1% +$5.87K 0.04% 227
2023
Q3
$514K Sell
7,223
-36
-0.5% -$2.69K 0.04% 234
2023
Q2
$559K Buy
+7,259
New +$562K 0.04% 213

Other funds holding CL

Summit Financial's CL Position: Q1 2026 in Review

Summit Financial increased its Colgate-Palmolive (CL) stake by 8.9% in Q1 2026, buying an estimated $110K and bringing the position to 15,063 shares worth $1.28M. The position accounts for 0.02% of the portfolio, ranked #695.

Summit Financial first reported a position in CL in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.39M in Q2 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Summit Financial held 15,063 shares of Colgate-Palmolive worth $1.28M as of Q1 2026.
  • Summit Financial bought 1,229 Colgate-Palmolive shares in Q1 2026, an estimated $110K.
  • Colgate-Palmolive made up 0.02% of Summit Financial's portfolio in Q1 2026, its #695 holding.
  • Summit Financial first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 12 quarters since.
  • Summit Financial's Colgate-Palmolive position peaked at $1.39M in Q2 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.